Exploratory clinical study to investigate safety and efficacy of TCD-51073 in patients with with Severe Heart Failure due to Chronic ischemic Heart Disease.(follow-up study)

Exploratory clinical study to investigate safety and efficacy of TCD-51073 in patients with with Severe Heart Failure due to Chronic ischemic Heart Disease.(follow-up study) - Exploratory clinical study to investigate safety and efficacy of TCD-51073 in patients with with Severe Heart Failure due to Chronic ischemic Heart Disease.(follow-up study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009926

Enrollment

Registered

2013-02-01

Start date

2013-02-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe heart failure due to chronic ischemic heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who are are enrolled in the first clinical study and complete examination and observation at the 26th week of transplantation. 2) Patients who live in Japan for two years after transplantation. 3) Patients who sign written informed consent prior to the clinical study.

Exclusion criteria

Exclusion criteria: 1) Patients who are judged to be inappropriate for the study by the investigator or the sub investigators.

Design outcomes

Primary

Measure	Time frame
Survival rate for two years after transplantation.	—

Countries

Japan

Contacts

Public Contactkazuotamada

Terumo Corporation Clinical Development Department

Michio_Satou@terumo.co.jp0465-81-4104

Outcome results